U.S. Physical Therapy’s (USPH) “Outperform” Rating Reaffirmed at Barrington Research

Barrington Research reissued their outperform rating on shares of U.S. Physical Therapy (NYSE:USPH) in a research report sent to investors on Thursday,Benzinga reports. They currently have a $108.00 price objective on the stock.

A number of other equities analysts also recently commented on USPH. Bank of America reissued a “neutral” rating and issued a $90.00 price objective (down previously from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st.

U.S. Physical Therapy Stock Up 2.6 %

Shares of U.S. Physical Therapy stock opened at $96.50 on Thursday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The stock has a market cap of $1.46 billion, a price-to-earnings ratio of 102.65, a PEG ratio of 4.10 and a beta of 1.38. The firm’s 50-day moving average is $84.95 and its two-hundred day moving average is $90.89. U.S. Physical Therapy has a 1 year low of $76.18 and a 1 year high of $113.63.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 15th will be issued a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 1.82%. The ex-dividend date is Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio is currently 187.23%.

Insider Transactions at U.S. Physical Therapy

In related news, Director Kathleen A. Gilmartin acquired 2,000 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were purchased at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the acquisition, the director now directly owns 18,904 shares in the company, valued at $1,627,445.36. The trade was a 11.83 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Nancy Ham sold 1,172 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $96.72, for a total transaction of $113,355.84. Following the completion of the sale, the director now owns 1,112 shares of the company’s stock, valued at $107,552.64. This trade represents a 51.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 6,896 shares of company stock valued at $656,940. Corporate insiders own 1.70% of the company’s stock.

Hedge Funds Weigh In On U.S. Physical Therapy

Several hedge funds have recently made changes to their positions in the company. Canada Pension Plan Investment Board purchased a new stake in U.S. Physical Therapy during the 2nd quarter valued at about $28,000. Innealta Capital LLC acquired a new stake in shares of U.S. Physical Therapy during the second quarter worth about $30,000. Quest Partners LLC boosted its position in U.S. Physical Therapy by 2,808.3% in the second quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after buying an additional 337 shares during the last quarter. Quarry LP increased its holdings in U.S. Physical Therapy by 1,291.9% in the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after buying an additional 478 shares during the period. Finally, Ridgewood Investments LLC purchased a new position in U.S. Physical Therapy during the 2nd quarter worth approximately $51,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.